100% Quality Guarantee
PhD-Level Technical Support
Key Features

APC Anti-Mouse IL-4 Antibody [11B11] (AGEL2059)

SKU AGEL2059
Product Type Antibody
Antibody Type Monoclonal Antibody
Reactivity Mouse
Applications FC
€107 - €275

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

APC Anti-Mouse IL-4 Antibody [11B11]

The Mouse IL-4 Monoclonal Antibody (APC-Conjugated, 11B11) from AssayGenie (Product Code: AGEL2059) is a valuable tool for researchers studying the cytokine IL-4 in mouse models. IL-4 is a key regulator of immune responses, playing a crucial role in allergy, asthma, and immunity to parasites. This monoclonal antibody specifically targets IL-4, allowing for precise detection and quantification in experimental samples.Developed for use in flow cytometry, this APC-conjugated antibody offers high sensitivity and specificity, making it ideal for analyzing IL-4 expression in various cell populations.

Its reliable performance ensures accurate results, facilitating detailed investigations into the role of IL-4 in immune modulation and disease pathogenesis.Researchers in immunology, allergy, and infectious diseases can benefit from the versatility and reliability of the Mouse IL-4 Monoclonal Antibody (APC-Conjugated, 11B11) from AssayGenie. By elucidating the functions of IL-4 in mouse models, this antibody enables deeper insights into immune regulation and the development of potential therapeutic strategies targeting IL-4-mediated pathways.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose